Skip to Main Content
Contribute Try STAT+ Today

Amid an ongoing opioid crisis in the U.S., a new federal government report finds that efforts to revise prescribing practices and provide treatments for people who have abused opioids continue to make progress, but also warned serious concerns remain and Covid-19 may complicate the picture.

In 2019, about one in four Medicare Part D beneficiaries received at least one prescription opioid. Specifically, 26% of beneficiaries, or 12.6 million of the 48.3 million people enrolled in the program, received opioids. This was a drop from the previous year, when 29% of beneficiaries received the addictive painkillers through Part D and, significantly, the fourth-consecutive year of decline.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.